Tumor growth-promoting effect of immunosuppressive substance in mice. 1989

M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
Biomedical Research Laboratories, Kureha Chemical Industry Co., Ltd., Tokyo, Japan.

The effect of immunosuppressive (IS) substance obtained from cancerous ascitic fluid on tumor growth and host immunity in plasmacytoma X5563-bearing C3H/He mice is described. IS substance given in three injections, before and after tumor inoculation caused: (a) enhanced tumor growth, (b) marked reduction in survival times, (c) inhibition on Con-A response of spleen cells. Depressed natural killer (NK) activity was observed in normal and tumor-bearing mice treated with IS substance. The data presented here suggest that IS substance suppresses both humoral and cellular immunoresponsiveness and tumor cells evade immune surveillance or immunologically mediated removal.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
June 1975, European journal of cancer,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
July 1980, Journal of the National Cancer Institute,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
November 1974, Science (New York, N.Y.),
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
June 1933, Proceedings of the National Academy of Sciences of the United States of America,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
January 1995, Transplant international : official journal of the European Society for Organ Transplantation,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
December 1959, Endocrinology,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
January 1995, Immunological investigations,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
September 1990, Acta endocrinologica,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
May 1933, The Journal of general physiology,
M Fujii, and N Takahashi, and T Fujii, and H Hayashi, and K Matsunaga, and T Furusho, and Y Omura, and C Yoshikumi
November 2003, Blood,
Copied contents to your clipboard!